why now, page-21

Harvett.Why would the MPS be trying to avoid our product anyway. I can't understand your argument. They obviously want our product or they wouldn't be trialing it.If we can't satisfy them no one else is currently going to. Fair enough by them to get us to tailor it to suit themselves because of the volume expected but if we get knocked back they're right back to square 1 and a long way from having anybody's product because the same process would have to be repeated all over again.Isn't it about curbing the drug problem which is why the time frame hasn't changed but the number used for trialing did.They need us as much as we need them. It might sound simplistic but it's the way i see it.